With a Sound Strategic Course, Estée Lauder Is Poised For Improving Sales and Profits
Estée Lauder, a leader in prestige beauty, has faced challenges recently due to innovation and distribution issues. However, the company is implementing a strategic plan to enhance efficiency, innovation, and marketing support, which Morningstar believes will bolster its competitive edge and lead to improved sales and profits. Despite these efforts, the shares are still considered a bargain.
Q2 Earnings Roundup: Medifast (NYSE:MED) And The Rest Of The Personal Care Segment
This article provides a Q2 earnings roundup for the personal care industry, highlighting the performance of several key companies. Medifast (MED) reported a strong quarter with revenues exceeding expectations and increased EPS guidance, while e.l.f. Beauty (ELF) stood out with significant revenue growth and analyst estimate beats. Conversely, Nature's Sunshine (NATR) experienced a disappointing quarter with misses on revenue, EBITDA, and EPS estimates.
Estée Lauder: Brand Investments Stand To Buoy Its Competitive Edge; Shares Still a Bargain
Estée Lauder is showing signs of recovery after three years of organic sales declines, with a 3% increase in fiscal 2026 sales and an improved adjusted gross margin. The company's brand investments are expected to strengthen its competitive position. The report suggests that despite past challenges, the shares remain a bargain.
Estee Lauder's Sound Strategic Course Should Manifest in Improving Sales and Margins Longer Term
Morningstar views Estee Lauder's strategic initiatives, including workforce reduction, leveraging scale, and supply chain enhancement, as prudent steps to bolster its innovation and marketing. While the company has faced challenges like lackluster innovation, these efforts are expected to improve sales and margins long-term, maintaining its strong global market share in prestige beauty.
Unilever PLC (UNA.AS) Stock Price, News, Quote & History
This Yahoo Finance page provides comprehensive information on Unilever PLC (UNA.AS) stock, including its current price, historical data, and key financial metrics. It details the company's segments (Beauty & Wellbeing, Personal Care, Home Care, Foods) and brands, offering insights into its market performance, analyst ratings, and financial health. The page serves as a resource for investors looking to research Unilever's stock.
The Estée Lauder Companies Inc. (EL) Stock Price, News, Quote & History
This page provides a detailed financial overview of The Estée Lauder Companies Inc. (EL), including its current stock price, market performance, and key financial metrics. It offers insights into the company's business operations, product portfolio, recent news, analyst ratings, and comparative data with similar companies in the Household & Personal Products sector. The content highlights Estée Lauder's market position, recent strategic announcements, and various financial performance indicators.
Is Edgewell Personal Care (EPC) Undervalued Or Is Its Recovery Already Priced In?
Edgewell Personal Care (EPC) has seen recent stock gains, with a 65.84% year-to-date return, despite longer-term declines. Analysts consider the stock 12% undervalued based on a fair value of $31.83, citing brand spending, cost savings, and expected profitability recovery. However, risks include shrinking mature categories and retailer pricing pressure, suggesting investors should review the full picture of rewards and warning signs.
SenesTech's rodent birth control products launch on sustainable marketplace Grove Collaborative.
SenesTech's Evolve® rodent birth control products will soon be available on Grove Collaborative's online marketplace, expanding access to eco-friendly rodent control solutions. This move leverages Grove Collaborative's reputation for sustainable products, aligning with Evolve's natural ingredients and non-toxic approach to pest management. The launch supports SenesTech's strategy to increase consumer availability through e-commerce and promote rodent birth control as a long-term pest management solution.
Colgate-Palmolive (NYSE:CL) Stock Price
This article provides an overview of Colgate-Palmolive (NYSE:CL) stock, highlighting its current market valuation, recent price performance, and analyst fair values. It details the company's financial health, including revenue, gross profit, and earnings, and describes its operating segments (Oral, Personal and Home Care; Pet Nutrition). The article also mentions recent news such as dividend announcements and updates on strategic narratives focusing on cost optimization and premium product mix.
Dual-class shares give a family trust extra sway at Estée Lauder (NYSE: EL)
An updated Schedule 13D/A filing reveals that the Trust Under Article 2 of The Zinterhofer 2008 Descendants Trust and Eric Louis Zinterhofer beneficially own 1.9% of Estée Lauder's Class A common stock. Due to the company's dual-class share structure, their 4,910,594 Class B shares translate to 3.5% of the aggregate voting power, granting them disproportionate influence. The filing also highlights transfer restrictions and rights of first offer among Lauder family stockholders under a pre-existing Stockholders' Agreement.
American Tower Keeps Quarterly Dividend at $1.79 per Share, Payable Oct. 20 to Holders of Record Sept. 30
American Tower Corporation announced it is maintaining its quarterly dividend at $1.79 per share. This dividend will be payable on October 20 to shareholders of record as of September 30. The company also presented at several financial conferences in September.
Interparfums secures 20-year extension of Roberto Cavalli license
Interparfums Inc. and Marquee Brands have extended their exclusive worldwide license agreement for Roberto Cavalli and Just Cavalli fragrances for an additional 20 years, through December 31, 2046. Interparfums has managed the Roberto Cavalli fragrance license since 2023, expanding the portfolio and launching its first "blockbuster" for the brand in 2025. This long-term extension highlights the strategic role of fragrance in the global development of Roberto Cavalli.
NORDSON CORP Insider Rutledge Joseph M Sells 684 Shares at $309.38 Each
Rutledge Joseph M, Vice President and CAO of NORDSON CORP (NASDAQ:NDSN), sold 684 shares of the company stock at $309.38 per share on September 15, 2026. This transaction reduced his holdings by approximately 24.3%, leaving him with 2,134 shares. The sale provides investors with insight into insider activity.
GXO Logistics CFO Christina Carvalho Awarded 21,309 RSUs on September 14, 2026
Christina Carvalho, Chief Accounting Officer of GXO Logistics, Inc., was awarded 21,309 Restricted Stock Units (RSUs) on September 14, 2026, as disclosed in a Form 4 filed with the SEC on September 16, 2026. These RSUs, acquired at no cost, will vest in two equal annual installments on September 14, 2027, and September 14, 2028, subject to her continued employment. Post-transaction, Carvalho beneficially owns 21,309 derivative securities.
HealthStream Completes $40 Million Private Placement with CEO Share Sale
HealthStream, Inc. announced the successful closing of a private securities transaction where it issued 1,355,932 common stock shares for $40.0 million to WJRJJ Ventures, LLC. Concurrently, CEO Robert A. Frist, Jr. sold 144,068 shares to the same investor for approximately $4.25 million, both priced at $29.50 per share. These transactions, approved by HealthStream's Audit Committee and disinterested board members due to related-party connections with Empath Nursing, Inc., are intended to fund general corporate purposes, including investments and strategic initiatives.
Walmart Fails to Shake Estée Lauder Brands’ Counterfeit Claims
A federal judge has denied Walmart's request to dismiss or narrow a trademark lawsuit brought by Estée Lauder and its brands regarding allegedly counterfeit cosmetics and fragrances sold on Walmart.com. The ruling allows the case to proceed, including claims involving products beyond the initial 17 tested by Estée Lauder. This case highlights the ongoing legal complexities of holding online marketplaces accountable for counterfeit goods sold by third-party sellers.
Estée Lauder’s Lawsuit Over Alleged Counterfeits Sold On Walmart Moves Forward, Says Report
A federal judge has allowed Estée Lauder to broaden its lawsuit against Walmart, which alleges that counterfeit luxury cosmetics and fragrances are being sold on Walmart.com by third-party vendors. The ruling denies Walmart's motion to dismiss and permits Estée Lauder to expand its claims beyond the initial 17 products tested as fake. This case could establish significant legal precedents regarding e-commerce platforms' responsibility for policing third-party sellers.
Estée Lauder Companies names two director nominees for 2026 annual meeting
Estée Lauder Companies has nominated Jean-Frédéric Dufour, CEO of Rolex SA, and Matthew E. Rubel, non-executive chairman of Holley Inc., as Class III director candidates. These nominations are for its upcoming annual meeting expected on November 17, 2026. This move expands the board candidate slate in anticipation of the 2026 annual stockholders meeting.
Zacks Industry Outlook Highlights Estee Lauder, e.l.f. Beauty, Coty and Helen of Troy
The Zacks Cosmetics industry faces challenges like cautious consumer spending, trade uncertainties, and supply-chain risks, leading to an underperformance compared to the S&P 500. Despite these headwinds, companies such as Estee Lauder, e.l.f. Beauty, Coty, and Helen of Troy are highlighted as well-positioned due to their focus on innovation, digital capabilities, and operational efficiency. The industry outlook is currently deemed "dull" by Zacks Industry Rank.
Innospec secures the win for the Regulatory & Compliance Excellence category in the Cosmetics Business Innovation Awards
Innospec has won the Regulatory & Compliance Excellence category at the first-ever Cosmetics Business Innovation Awards. The company was recognized for its novel human-focused methodologies to test the safety of cosmetic ingredients, providing an ethical alternative to animal testing. Judge Emma Meredith praised Innospec's commitment to advancing regulatory acceptance of non-animal alternative methods, which could lead to significant industry-wide change.
EL Archives
This page provides news and articles related to Estee Lauder Cos. Inc - Class A (EL). It includes stock performance data, earnings reports, analyst predictions, and recent news articles discussing the company's performance, market trends, and comparisons with other companies. The content also features insider trading disclosures and various investment analyses concerning Estee Lauder.
Estee Lauder exec VP La Lande sells $802k in company shares
Rashida La Lande, Executive Vice President at Estee Lauder Companies Inc., sold 7,766 shares of Class A Common Stock for approximately $802,383 on August 28, 2026. This transaction followed the withholding of 6,591 shares for tax obligations and the vesting of 14,357 shares on August 27, 2026. Additionally, Ms. La Lande received new grants of Restricted Stock Units and stock options.
Estee Lauder exec VP La Lande sells $802k in company shares By Investing.com
Rashida La Lande, Executive Vice President and General Counsel at Estee Lauder Companies Inc., sold 7,766 shares of Class A Common Stock for approximately $802,383 on August 28, 2026. This transaction followed the withholding of shares to cover tax obligations and the acquisition of shares from vested Restricted Stock Units. Additionally, Ms. La Lande received new grants of RSUs and stock options.
Estee Lauder exec VP La Lande sells $553,896 in company stock
Rashida La Lande, Executive Vice President and General Counsel at The Estee Lauder Companies Inc. (EL), sold 5,564 shares of company stock worth approximately $553,896 on August 21, 2026. This transaction occurred on the same day she acquired an equal number of shares through stock option exercises for about $516,728. Following these activities, La Lande directly owns no Class A Common Stock but retains 11,129 derivative securities.
Estee Lauder exec VP La Lande sells $553,896 in company stock
Rashida La Lande, EVP and General Counsel at The Estee Lauder Companies Inc., sold 5,564 shares of company stock for $553,896 on August 21, 2026, after acquiring an equal number of shares through stock option exercise. Following these transactions, she directly owns no Class A Common Stock but holds 11,129 derivative securities. This comes as EL stock has recently surged, and the company reported better-than-expected Q4 2026 results, leading to positive analyst outlooks.
3 Beauty Stocks Poised to Gain From Innovation and Digital Reach
This article highlights three beauty stocks – Bath & Body Works (BBWI), The Estee Lauder Companies (EL), and Coty (COTY) – that are well-positioned for growth due to their focus on innovation, digital engagement, and adaptation to evolving consumer preferences. The beauty industry is characterized by frequent product usage, new launches, and a shift towards efficacy, transparency, and personalized solutions. The companies discussed are leveraging science-led innovation, ethical ingredient sourcing, and multi-channel digital strategies to capture market opportunities.
Bernstein raises Procter & Gamble stock price target on marketing shift
Bernstein SocGen Group increased its price target for Procter & Gamble (NYSE:PG) stock to $149 from $148, maintaining a "Market Perform" rating. The firm highlighted P&G's significant marketing spend and the increasing challenge of maintaining marketing effectiveness as consumers shift from linear TV to social media. Despite these headwinds, P&G remains financially strong with $87 billion in revenue and a $340 billion market cap, alongside recent strategic moves like the acquisition of Thorne and varied analyst opinions on its growth outlook.
Estée Lauder (EL) Stock Slips As Margin Gains Meet Cash Flow Concerns
Estée Lauder's stock slipped despite significant margin repair in its Q4 2026 earnings, driven by its Profit Recovery and Growth Plan. While the company showed improved profitability and sales growth across regions and channels, concerns remain about cash flow due to higher restructuring payments and working capital, leading to a cautious market reaction. The article discusses both the bullish aspects of margin improvement and strategic execution, and the bearish concerns regarding cash-intensive turnaround and travel retail volatility.
HomeTeam Pest Defense Surpasses 2 Million Taexx® Built-In Pest Control System Installations
HomeTeam Pest Defense has reached a significant milestone, surpassing 2 million installations of its Taexx built-in pest control system. This system, installed during new home construction, targets pests within wall voids and provides a convenient, weather-protected, and family-friendly pest control solution. The company, celebrating its 30th anniversary, partners with over 1,000 builders nationwide, offering an innovative way to add value to new homes.
B. Riley Financial Reiterates "Neutral" Rating for Estee Lauder Companies (NYSE:EL)
B. Riley Financial has reaffirmed a "Neutral" rating for Estee Lauder Companies (NYSE:EL), increasing its price target from $85 to $100, which is about 3% above its previous close. Despite beating quarterly expectations with $3.64 billion in revenue and $0.39 EPS, and maintaining fiscal 2027 EPS guidance, the stock holds a consensus "Hold" rating with a $97.50 target. Analysts note valuation risk due to elevated forward earnings multiples relative to expected growth.
From Product Discovery to Brand Storytelling: How AI Is Reshaping Qixi Gifting on JD.com
JD.com is leveraging AI and 3D technology to revolutionize the Qixi Festival gifting experience. The company has seen a significant increase in searches for luxury items and brands launching new products, indicating strong consumer demand. JD.com's innovations include glasses-free mobile 3D shopping and generative AI for luxury brand storytelling, enhancing product discovery, engagement, and creative content for customers.
Morgan Stanley Upgrades Merck & Co. to Overweight From Equalweight, Adjusts PT to $179 From $116
Morgan Stanley has upgraded Merck & Co. (MRK) from Equalweight to Overweight, simultaneously increasing its price target for the pharmaceutical company to $179 from $116. This positive revision reflects a more optimistic outlook on Merck's stock performance. The article also notes similar upgrades and price target adjustments from BMO Capital and Jefferies, indicating a broader positive sentiment among analysts for Merck & Co.
TD Cowen Adjusts Price Target on Workday to $220 From $155, Maintains Hold Rating
TD Cowen has increased its price target for Workday (NASDAQ: WDAY) shares to $220 from $155, while maintaining a Hold rating on the stock. This adjustment reflects a significant positive revision in the analyst's outlook for the company. The article also lists other recent analyst adjustments for Workday, with several firms raising their price targets but some also downgrading the stock.
RBC Downgrades Merck & Co. to Sector Perform From Outperform, Adjusts PT to $150 From $142
RBC has downgraded Merck & Co. (MRK) from an "Outperform" rating to "Sector Perform." The bank also adjusted its price target for Merck & Co. shares, raising it to $150 from the previous $142. This change in rating and price target was reported on August 20, 2026.
SBA Communications director Krouse sells $54,802 in SBAC shares
George R Krouse Jr., a director at SBA Communications Corp. (NASDAQ:SBAC), sold 300 shares of the company’s Class A Common Stock for $54,802 on August 17, 2026. Following this transaction, Krouse directly holds 8,511.636 shares and beneficially owns various restricted stock units. The sale occurred after SBA Communications surpassed Q2 2026 earnings expectations and increased its full-year guidance, with InvestingPro analysis suggesting the stock is undervalued despite a recent decline.
BioNTech SE Stock Pops As Traders Refocus On Oncology
BioNTech SE (BNTX) stock surged by 23.44% despite lower COVID-19 revenues and wider losses in Q2 2026, as traders are now focusing on the company's strong oncology pipeline. BioNTech boasts a substantial cash pile of €16.6 billion, active share buybacks, and 14 pivotal oncology trials, positioning it for future growth. The European Commission's approval of an updated COVID vaccine and a planned CEO transition by 2027 further support the shift towards a diversified biopharma strategy.
OPEN Raises Zero-Cost Capital As Buyback Signals Confidence
Opendoor Technologies Inc. (OPEN) is raising $650 million through 0% convertible senior notes due 2030, securing $440 million in net growth capital. This strategic move aims to fund home inventory and scale its iBuying engine, while the company also repurchased 5% of its shares outstanding. Management structured the deal to protect existing shareholders from dilution, with no net share issuance expected unless the stock trades above $10.38, signaling confidence despite ongoing profitability challenges.
Alpha Teknova at Micro-Cap Virtual Conference: clinical growth in focus
Alpha Teknova recently presented at the Micro-Cap Virtual Conference, highlighting significant growth in its clinical products division and improved financial performance. The company reported record Q2 2025 revenue of $12.2 million and raised its full-year guidance, with adjusted EBITDA expected to turn positive in 2027. Alpha Teknova emphasized its operational efficiency, capacity for substantial revenue growth within its current infrastructure, and the strategic importance of its Clinical Solutions business, which is serving an increasing number of therapies in clinical trials.
So-Young to report Q2 2026 earnings before US m...
So-Young International Inc., a leading aesthetic treatment platform in China, is scheduled to announce its financial results for the second quarter of 2026 on August 31, before the US market opens. The company will also host an earnings call on the same day to discuss its performance and future outlook. So-Young connects consumers with aesthetic services and is positioned for growth due to its strong brand and supply chain.
NEOS’s ‘Boosted’ S&P Fund Pays 17% While the Nasdaq Version Pays 21%
NEOS has launched "boosted" versions of its high-income ETFs, XSPI and XQQI, which offer higher distribution rates than the original SPYI. XSPI provides a roughly 16.8% forward distribution rate by using 150% notional S&P 500 exposure, while XQQI, focusing on the Nasdaq-100, delivers about a 20.1% rate. These boosted funds come with increased risk due to leverage, higher expense ratios, and a short track record since their launch in February 2026.
AIXC Stock Whipsaws Higher As Traders Hunt Volatility
AIxCrypto Holdings Inc. (AIXC) stock is experiencing significant volatility, whipsawing higher despite negative sentiment from regulatory crackdowns and weak financial fundamentals. The article highlights AIXC's extreme price swings, making it attractive to nimble traders looking for short-term opportunities, while noting its deep losses and negative returns. The company's balance sheet, however, shows some resilience with working capital and minimal debt, providing a "story runway" for speculative trading.
YJ Stock Pulls Back As Volatility Grips Yunji Inc.
Yunji Inc. (YJ) stock has experienced significant volatility, with an early August spike near $14 followed by a retreat to the low $1s, demonstrating boom-and-bust momentum. Despite deep value pricing indicated by its price-to-sales ratio near 0.2 and price-to-book around 0.07, and a strong cash position of over $219.4M, the company has faced past revenue declines. The article advises treating YJ as a short-term trading vehicle rather than a long-term investment, emphasizing disciplined entries and risk management due to its volatile nature.
The Estée Lauder Companies Inc. Declares Quarterly Cash Dividend on Class A and Class B Common Stock, Payable on September 15, 2026
The Estée Lauder Companies Inc. has announced a quarterly cash dividend of $0.35 per share for its Class A and Class B Common Stock. This dividend is payable on September 15, 2026, to stockholders recorded as of the close of business on August 31, 2026. The announcement was published on August 19, 2026, at 06:00 am EDT.
Ester Loop Infinite Technologies secures Multi-Year LOI with Leading Global Sports Brand for Up to 15,000 MT per Year
Ester Loop Infinite Technologies (ELITe), a joint venture between Ester Industries Limited and Loop Industries, Inc., has secured a multi-year Letter of Intent (LOI) with a major global sports brand. This agreement is for the annual supply of up to 15,000 metric tons of Loop™ PET Fiber Grade resin from ELITe's upcoming facility in India, which is expected to become operational in 2028. This LOI, following a previous commitment from Nike, significantly covers a substantial portion of the facility's planned annual capacity, validating the market demand for circular, textile-to-textile recycled polyester.
Philips and GE investigating Clop ransomware data theft claims
Tech giants General Electric (GE) and Philips are investigating claims by the Clop ransomware gang that their systems were breached and data was stolen. Philips confirmed a contained incident related to internal data, while GE is assessing the claim. This follows a similar claim against Shell, and the Clop gang has listed all three companies among 43 new victims, likely targeted via a critical vulnerability in PTC Windchill and PTC FlexPLM software.
Estée Lauder Companies (EL) Expands Color Science Research For Shade Matching
Estée Lauder Companies (EL) has announced a research collaboration with the University of Leeds and Dr. Kaida Xiao to advance color science for complexion products, aiming to improve shade matching accuracy in luxury foundations. This initiative aligns with Estée Lauder's strategy to boost product innovation, targeting over 25% of sales from new products by fiscal 2026. The research is expected to inform future product development and help defend pricing power in the competitive cosmetics market.
3 Stocks Possibly Trading Below Their Estimated Value In August 2026
This article identifies three U.S. stocks—Landstar System (LSTR), Estée Lauder Companies (EL), and Glacier Bancorp (GBCI)—that are potentially trading below their estimated fair value in August 2026, according to cash flow valuations. Despite varying revenue growth forecasts, all three companies show strong projected annual earnings growth, suggesting potential investment opportunities in a market with positive momentum. The analysis highlights their respective estimated discounts to fair value and operational segments.
Nature's Sunshine Cuts Full-Year Guidance as China Slump Offsets Digital Surge
Nature's Sunshine Products reported Q2 revenue and EPS below analyst estimates, leading to a cut in full-year guidance for revenue and EBITDA. This downward revision was primarily due to an unexpected 20% decline in revenue from China and adverse currency movements, despite strong digital sales growth and significant social commerce surge. The company remains focused on its "Vision for Growth" plan, aiming for $1 billion in revenue and a 15% EBITDA margin, supported by digital expansion, geographic penetration, and strategic M&A.
Half Year 2026 WPP PLC Earnings Call Transcript
WPP PLC reported its Half Year 2026 earnings, with like-for-like net sales down 4.7% but showing sequential improvement. The company highlighted strong new business wins, improved client retention, and strategic advancements in AI integration and new practice launches. Despite challenges like declining EPS and persistent top-line pressures, WPP sees growth in specific regions and sectors, alongside continued efforts in asset disposals.
Barfresh Food Group Inc. (BRFH) Reports Q2 Loss, Lags Revenue Estimates
Barfresh Food Group Inc. (BRFH) reported a Q2 loss of $0.12 per share, missing the Zacks Consensus Estimate of a $0.05 loss, and also lagged revenue estimates with $4.71 million against an expected $5.36 million. The company's shares have declined 37.2% year-to-date, and its Zacks Rank #3 (Hold) suggests it will perform in line with the market. Investors await management's commentary and future earnings estimates for further guidance.
